Anthony Hickey, Ph.D., Distinguished Fellow (appointed June 2012), is a senior research pharmacologist at RTI. Dr. Hickey has more than 30 years of academic and research experience in pulmonary biology, aerosol physics, powder dynamics, pharmacokinetics and drug disposition, formulation design, and device development.
Since joining RTI in 2011, he has conducted research related to pulmonary drug and vaccine delivery for tuberculosis treatment and therapy. Additionally, Dr. Hickey is an adjunct professor of biomedical engineering at the University of North Carolina at Chapel Hill School of Medicine, emeritus professor of molecular pharmaceutics at the University of North Carolina at Chapel Hill Eshelman School of Pharmacy, and founder and president of Cirrus Pharmaceuticals, Inc.
He has received many awards and honors and is an active member of several professional societies and committees, including the American Association for the Advancement of Science, American Association for Aerosol Research, and the Society of Toxicology. He is a fellow of the Society of Biology, the American Association of Pharmaceutical Scientists, and the American Association for the Advancement of Science.
Dr. Hickey holds 25 patents and has authored numerous books, book chapters, and more than 250 journal articles.